1The adams super center for brain studies (The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, The Elton Laboratory for Neuroendocrinology, Tel Aviv 69978 - Israel)
Abstract : NAP (generic name, davunetide) is an active fragment of activity-dependent neuroprotective protein (ADNP). ADNP-/- embryos exhibit CNS dysgenesis and die in utero. ADNP+/- mice survive but demonstrate cognitive dysfunction coupled with microtubule pathology. NAP treatment ameliorates, in part, ADNP-associated dysfunctions. The microtubule, stable tubule-only polypeptide (STOP) knockout mice were shown to provide a reliable model for schizophrenia. Here, STOP-/- as well as STOP+/- showed schizophrenia-like symptoms (hyperactivity) that were ameliorated by chronic treatment with the antipsychotic drug, clozapine. Daily intranasal NAP treatment significantly decreased hyperactivity in the STOP+/- mice and protected visual memory.
https://www.hal.inserm.fr/inserm-00498115
Contributor : Annie Andrieux <>
Submitted on : Thursday, April 28, 2011 - 5:57:40 PM Last modification on : Friday, November 6, 2020 - 3:47:26 AM Long-term archiving on: : Friday, December 2, 2016 - 5:47:44 PM
File
Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed
until : jamais